Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label drug-drug interaction study of BMS-790052 and tenofovir in healthy subjects
NL-OMON36725Active, not recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of daclatasvir and tenofovir in hepatitis C virus infection, sponsored by Bristol Myers Squibb. Primary endpoint: Pharmacokinetics. Started Jan 2011; status: active, not recruiting.
02
Drugs
daclatasvirtenofovir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON36725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36725.